Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

George R. Blumenschein | Researchclopedia

Back to researchers

George R. Blumenschein

The University of Texas MD Anderson Cancer Center ORCID

713

Works

41,815

Citations

81

h-index

243

i10-index

Research Topics

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Lung Cancer Research Studies

Affiliations

Northwestern University2012–2012

University of Maryland, Baltimore2011–2013

Christiana Care Health System2007–2007

Dartmouth–Hitchcock Medical Center2010–2010

Fox Chase Cancer Center2015–2015

Top Works

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei,L. Paz-Ares,et al.

20159,393 citations

Cancer Immunotherapy and Biomarkers

Lung Cancer Diagnosis and Treatment

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris,George R. Blumenschein,et al.

20164,974 citations

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

David P. Carbone,Martin Reck,et al.

20172,557 citations

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez,Chad Tang,et al.

20191,236 citations

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers,Lixia Diao,et al.

20121,115 citations

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Daniel R. Gomez,George R. Blumenschein,et al.

20161,066 citations

The BATTLE Trial: Personalizing Therapy for Lung Cancer

Edward S. Kim,Roy S. Herbst,et al.

2011885 citations

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

Robert L. Ferris,George R. Blumenschein,et al.

2018787 citations

Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion

Sewa S. Legha,Robert S. Benjamin,et al.

1982769 citations